JP2024543016A5 - - Google Patents
Info
- Publication number
- JP2024543016A5 JP2024543016A5 JP2024525632A JP2024525632A JP2024543016A5 JP 2024543016 A5 JP2024543016 A5 JP 2024543016A5 JP 2024525632 A JP2024525632 A JP 2024525632A JP 2024525632 A JP2024525632 A JP 2024525632A JP 2024543016 A5 JP2024543016 A5 JP 2024543016A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273777P | 2021-10-29 | 2021-10-29 | |
| US63/273,777 | 2021-10-29 | ||
| PCT/US2022/078991 WO2023077126A1 (en) | 2021-10-29 | 2022-10-31 | Trans-cyclooctene conjugates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024543016A JP2024543016A (ja) | 2024-11-19 |
| JPWO2023077126A5 JPWO2023077126A5 (https=) | 2025-11-11 |
| JP2024543016A5 true JP2024543016A5 (https=) | 2025-11-11 |
Family
ID=84463062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525632A Pending JP2024543016A (ja) | 2021-10-29 | 2022-10-31 | トランス－シクロオクテンコンジュゲート |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4422693A1 (https=) |
| JP (1) | JP2024543016A (https=) |
| CN (1) | CN118414169A (https=) |
| WO (1) | WO2023077126A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4669357A1 (en) * | 2023-02-21 | 2025-12-31 | Tambo, Inc. | TRANS-CYCLOOCTENE CONJUGATES |
| CN119638848A (zh) * | 2023-09-18 | 2025-03-18 | 深圳华大生命科学研究院 | Cd3抗体与荧光素酶的融合蛋白及其应用 |
| WO2025127934A1 (en) * | 2023-12-13 | 2025-06-19 | Tagworks Pharmaceuticals B.V. | Trans-cyclooctene with improved t-linker |
| WO2025174248A1 (en) * | 2024-02-16 | 2025-08-21 | Tagworks Pharmaceuticals B.V. | Trans-cyclooctenes with "or gate" release |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR104E (https=) | ||||
| WO2012074840A2 (en) * | 2010-11-22 | 2012-06-07 | The General Hospital Corporation | Compositions and methods for in vivo imaging |
| US10130711B2 (en) | 2013-06-19 | 2018-11-20 | The Regents Of The University Of California | Chemical structures for localized delivery of therapeutic agents |
| ES2880468T3 (es) | 2014-03-14 | 2021-11-24 | Univ California | Conjugados de TCO y métodos para el suministro de agentes terapéuticos |
| JP6823067B2 (ja) | 2015-09-10 | 2021-01-27 | タンボ・インコーポレイテッド | 生体直交型組成物 |
| ES2983582T3 (es) | 2017-04-07 | 2024-10-23 | Tambo Inc | Composiciones bioortogonales |
| ES2975330T3 (es) * | 2018-05-04 | 2024-07-04 | Tagworks Pharmaceuticals B V | Compuestos que comprenden un enlazador para aumentar la estabilidad del trans-cicloocteno |
| CN110496233B (zh) * | 2019-09-05 | 2022-07-19 | 复旦大学附属中山医院 | 一种spect显像剂及其标记前体及其制备方法、组合物和用途 |
-
2022
- 2022-10-31 EP EP22821794.9A patent/EP4422693A1/en active Pending
- 2022-10-31 WO PCT/US2022/078991 patent/WO2023077126A1/en not_active Ceased
- 2022-10-31 JP JP2024525632A patent/JP2024543016A/ja active Pending
- 2022-10-31 CN CN202280083958.4A patent/CN118414169A/zh active Pending